• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用质量平衡法建立新的稳定性指示反相高效液相色谱法,用于测定曲美替尼醋酸盐的有关物质和含量。

New stability indicating RP-HPLC methods for the determination of related substances and assay of trametinib acetic acid: a mass balance approach.

机构信息

Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam, Andhra Pradesh, 530003, India.

Research & Development, Aurobindo Pharma Ltd. Research Centre-II, Indrakaran, Sangareddy District, Hyderabad, Telangana, 502329, India.

出版信息

Anal Sci. 2024 Nov;40(11):2005-2015. doi: 10.1007/s44211-024-00633-4. Epub 2024 Jul 30.

DOI:10.1007/s44211-024-00633-4
PMID:39080194
Abstract

New stability indicating related substances and assay methods for trametinib acetic acid by RP-HPLC have been developed and validated through forced degradation and mass balance studies for the first time. In related substances (RS) method, trametinib acetic acid was successfully separated from its six related substances namely, cyclopropanamide impurity, desiodo trametinib, desacetyl trametinib, trione acetamide intermediate, trione intermediate, and trione PTSA intermediate using YMC-Triart C18 (150 × 4.6 mm, 3 µm) column. Orthophosphoric acid (0.15%) in water was used as buffer. Gradient elution was programmed using mobile phase-A (buffer and acetonitrile mixture in 80:20 v/v ratio) and mobile phase-B (buffer and acetonitrile mixture in 20:80 v/v ratio). Acetonitrile and methanol mixture (1:1 v/v) was used as diluent. Flow rate, injection volume, column temperature, and wavelengths were kept as 0.8 mL/min, 10 µL, 55 °C, and 240 nm, respectively. Desacetyl trametinib and cyclopropanamide impurity were identified as potential degradation impurities in acid and base degradation conditions, respectively. Assay method specific to above six related substances was also developed. Assay of forced degradation samples was also determined, and the mass balance was established by adding total impurities formed in RS method to assay of trametinib acetic acid.

摘要

首次通过强制降解和物料平衡研究,开发并验证了用于曲美替尼醋酸盐的有关物质和含量测定的反相高效液相色谱法(RP-HPLC)新方法,具有稳定性指示能力。在有关物质(RS)方法中,使用 YMC-Triart C18(150×4.6mm,3μm)柱,成功地将曲美替尼醋酸盐与其六种有关物质(环丙酰胺杂质、去碘曲美替尼、去乙酰曲美替尼、三酮乙酰胺中间产物、三酮中间产物和三酮 PTSA 中间产物)分离。以 0.15%正磷酸水溶液作为缓冲液。采用梯度洗脱程序,流动相 A(缓冲液和乙腈的 80:20 v/v 混合比)和流动相 B(缓冲液和乙腈的 20:80 v/v 混合比)。乙腈和甲醇混合液(1:1 v/v)用作稀释剂。流速、进样量、柱温、波长分别保持在 0.8mL/min、10μL、55°C 和 240nm。在酸和碱降解条件下,分别鉴定出去乙酰曲美替尼和环丙酰胺杂质为潜在的降解杂质。还开发了专门针对上述六种有关物质的含量测定方法。对强制降解样品进行了含量测定,并通过将 RS 方法中形成的总杂质加入到曲美替尼醋酸盐的含量测定中,建立了质量平衡。

相似文献

1
New stability indicating RP-HPLC methods for the determination of related substances and assay of trametinib acetic acid: a mass balance approach.采用质量平衡法建立新的稳定性指示反相高效液相色谱法,用于测定曲美替尼醋酸盐的有关物质和含量。
Anal Sci. 2024 Nov;40(11):2005-2015. doi: 10.1007/s44211-024-00633-4. Epub 2024 Jul 30.
2
A validated specific stability-indicating RP-HPLC assay method for Ambrisentan and its related substances.一种经过验证的用于安立生坦及其相关物质的特定稳定性指示反相高效液相色谱测定方法。
J Chromatogr Sci. 2014 Sep;52(8):818-25. doi: 10.1093/chromsci/bmt121. Epub 2013 Aug 7.
3
Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach.阿哌沙班片剂剂型中九种杂质测定的稳定性指示反相高效液相色谱法的开发与验证。采用设计质量方法进行稳健性研究。
Biomed Chromatogr. 2020 Jan;34(1):e4719. doi: 10.1002/bmc.4719. Epub 2019 Nov 19.
4
A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.在药物制剂中存在降解产物和其工艺相关杂质的情况下,对双嘧达莫进行稳定性指示的反相高效液相色谱法的验证。
Biomed Chromatogr. 2022 Jan;36(1):e5247. doi: 10.1002/bmc.5247. Epub 2021 Oct 21.
5
Impurity assessment, development and validation of an RP-HPLC method for the determination of eleven potential impurities of eltrombopag precursor.杂质评估、反相高效液相色谱法测定血小板生成素前体 11 种潜在杂质的方法开发与验证
J Pharm Biomed Anal. 2024 Jun 15;243:116085. doi: 10.1016/j.jpba.2024.116085. Epub 2024 Mar 6.
6
Stability Indicating Method Development and Validation for the Estimation of Bempedoic Acid by RP-HPLC.反相高效液相色谱法测定贝匹地酸的稳定性指示方法开发与验证。
Drug Metab Bioanal Lett. 2024;17(1):23-33. doi: 10.2174/0118723128278080240404052506.
7
A validated stability-indicating RP-HPLC assay method for Amsacrine and its related substances.一种经过验证的用于测定安吖啶及其相关物质的稳定性指示反相高效液相色谱分析方法。
J Chromatogr Sci. 2011 Aug;49(7):489-94. doi: 10.1093/chrsci/49.7.489.
8
Development and validation of a reversed-phase ultra-performance liquid chromatographic method for assay of lacidipine and related substances.一种用于测定拉西地平及其有关物质的反相超高效液相色谱法的建立与验证。
J AOAC Int. 2011 Nov-Dec;94(6):1800-6. doi: 10.5740/jaoacint.10-223.
9
Development and validation of a stability-indicating HPLC method for determination of voriconazole and its related substances.一种用于测定伏立康唑及其相关物质的稳定性指示高效液相色谱法的开发与验证
J Chromatogr Sci. 2009 Aug;47(7):594-8. doi: 10.1093/chromsci/47.7.594.
10
QbD-based stability-indicating liquid chromatography (RP-HPLC) method for the determination of flurbiprofen in cataplasm.基于质量源于设计的稳定性指示液相色谱法(反相高效液相色谱法)测定巴布剂中氟比洛芬的含量
Biomed Chromatogr. 2023 Apr;37(4):e5580. doi: 10.1002/bmc.5580. Epub 2023 Jan 24.

本文引用的文献

1
Simultaneous quantification of dabrafenib, hydroxy-dabrafenib and trametinib in human plasma by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法同时定量测定人血浆中的 dabrafenib、羟基-dabrafenib 和 trametinib。
J Pharm Biomed Anal. 2021 Jan 30;193:113718. doi: 10.1016/j.jpba.2020.113718. Epub 2020 Oct 27.
2
Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.开发并验证了一种灵敏的液相色谱串联质谱法,用于同时测定人血清和血浆中的十种激酶抑制剂。
Anal Bioanal Chem. 2021 Jan;413(2):599-612. doi: 10.1007/s00216-020-03031-7. Epub 2020 Nov 6.
3
HPLC methods for quantifying anticancer drugs in human samples: A systematic review.
用于定量分析人体样本中抗癌药物的高效液相色谱法:一项系统综述。
Anal Biochem. 2020 Dec 1;610:113891. doi: 10.1016/j.ab.2020.113891. Epub 2020 Aug 5.
4
Development of forced degradation and stability indicating studies of drugs-A review.药物强制降解及稳定性指示研究的进展——综述
J Pharm Anal. 2014 Jun;4(3):159-165. doi: 10.1016/j.jpha.2013.09.003. Epub 2013 Sep 17.
5
Simultaneous quantification of dabrafenib and trametinib in human plasma using high-performance liquid chromatography-tandem mass spectrometry.使用高效液相色谱-串联质谱法同时定量测定人血浆中的达拉非尼和曲美替尼。
J Pharm Biomed Anal. 2016 Jun 5;125:270-9. doi: 10.1016/j.jpba.2016.03.049. Epub 2016 Mar 25.
6
Development of validated stability-indicating assay methods--critical review.经过验证的稳定性指示分析方法的开发——批判性综述
J Pharm Biomed Anal. 2002 Jun 15;28(6):1011-40. doi: 10.1016/s0731-7085(02)00047-x.